NRD
Nebula Research & Development’s Ultragenyx Pharmaceutical RARE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-8,876
| Closed | -$373K | – | 1114 |
|
|
2024
Q4 | $373K | Buy |
8,876
+4,655
| +110% | +$196K | 0.04% | 652 |
|
|
2024
Q3 | $234K | Buy |
+4,221
| New | +$234K | 0.03% | 790 |
|
|
2023
Q2 | – | Sell |
-8,050
| Closed | -$323K | – | 429 |
|
|
2023
Q1 | $323K | Buy |
+8,050
| New | +$323K | 0.57% | 5 |
|